Financials
Income statement
| Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|
| Total reported revenue | 1.6B | 1.7B | 1.7B | 1.7B |
| Cost of revenue | 1.1B | 1.2B | 1.2B | 1.1B |
| Gross profit | 506M | 514M | 482M | 572M |
| Operating expense | ||||
| Research & development | 73M | 78M | 97M | 86M |
| Selling general and admin | 213M | 248M | 257M | 249M |
| Other operating expenses | 51M | 41M | 32M | 31M |
| Operating income | 169M | 147M | 96M | 206M |
| Non operating interest income | ||||
| Income | 6M | 5M | 5M | 5M |
| Expense | 37M | 28M | 26M | 36M |
| Other income expense | — | — | — | — |
| Pretax income | 72M | 29M | -83M | 153M |
| Tax provision | 27M | 27M | 50M | 153M |
| Net income | 45M | 2M | -133M | 0 |
| Basic EPS | 0.5 | 0.0 | -1.3 | 0.0 |
| Diluted EPS | 0.5 | 0.0 | -1.3 | 0.0 |
| Basic average shares | 102.5M | 103.1M | 103.9M | 104.7M |
| Diluted average shares | 103.3M | 103.6M | 104.6M | 105.4M |
| EBITDA | 332M | 306M | 370M | 375M |
| Net income from continuing op. | 45M | 2M | -133M | 0 |
| Minority interests | 5M | -5M | 1M | 0 |
| Preferred stock dividends | 0 | 0 | 0 | 0 |